Ebola drug study canceled due to declining cases



This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

DAKAR, Senegal (AP) — Doctors Without Borders says that human testing on a potential Ebola drug is being stopped because there aren't enough patients because of a decline in Ebola cases.

The drop-off in Ebola infections is good news for Liberia, but it means there are not enough sick people to take part in the study.

The announcement Wednesday by Doctors Without Borders comes days after the drug's manufacturer said it would no longer take part.

The drug brincidofovir has been used to treat other viruses and doctors wanted to study whether it could also cure Ebola. There is no licensed treatment for the disease that has killed about 9,000 people in West Africa over the past year.

On Monday, human testing got under way in Liberia for two potential vaccines to prevent Ebola.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

    SIGN UP FOR THE KSL.COM NEWSLETTER

    Catch up on the top news and features from KSL.com, sent weekly.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast